Naloxone Hydrochloride Nasal Spray, $19 per unit, 24 units per case

The State of California Department of Health Care Services has awarded a non-information technology goods contract valued at $1,252,176.00 to PADAGIS PARENT HOLDING, effective April 10, 2026. This contract procurement encompasses the supply of Naloxone Hydrochloride Nasal Spray, a medication used for opioid overdose reversal. The contract specifies a unit price of $456 per unit for a total quantity of 2,746 units, with the product formatted as 24 units per case at a base unit cost of $19.

The contract represents a straightforward goods procurement by the State of California's healthcare division to support medication distribution and emergency response capabilities. While specific performance locations, contract period duration, and any potential cumulative value or renewal terms are not detailed in the available contract documentation, the award establishes PADAGIS PARENT HOLDING as the prime contractor responsible for supplying the specified naloxone inventory to the Department of Health Care Services.